1st July 2024 by Dr Louise Hudman
This is a new guideline from Nice advising that empagliflozin can now be used in the treatment of CKD. It was published in December 2023.
Dapagliflozin was recommended by Nice for the treatment of CKD back in 2022. It has slightly tighter prescribing recommendations.
You can also read more on CKD in my previous blog.
Clinical psychologists to give GP talk on ADHD and autism outcomes
NASGP members are invited to a new talk, 'Better outcomes for patients with ADHD and autism', by Dr Alesia Moulton-Perkins and Dr Jessie Gough.
Tirzepatide for managing overweight and obesity
This is guidance from NICE on tirzepatide (Mounjaro) in overweight and obesity was first published in December 2024.
Immunotherapy (Acarizax) for dust mite allergy and allergic rhinitis
NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.
"Using LocumDeck has been an amazing experience, it’s truly game changing. It offers much more control, flexibility and transparency compared to using a locum agency. The ability to set the session terms and allowing practices to instant book makes the whole process seamless and hassle-free. "
Dr Daniel Nai, GP, Essex